Assessment of ocrelizumab impact on neurofilament levels in multiple sclerosis patients
Multiple sclerosis (MS) is a debilitating neurological disease characterized by inflammation, demyelination, and neurodegeneration in the central nervous system. Despite extensive research, the pathology of MS remains incompletely understood. Ocrelizumab (OCRE), a monoclonal antibody targeting CD20-...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sciendo
2024-07-01
|
| Edice: | Romanian Journal of Laboratory Medicine |
| Témata: | |
| On-line přístup: | https://doi.org/10.2478/rrlm-2024-0019 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|